Patent · US Active

Substituted imidazo[1,5-a]pYRAZINES for modulation of IRE1

US10131668B2 · kind B2 · utility

2Cited by

153References

20Claims

0Family size

Assignees

The Regents of the University of California · US
University of Washington through its Center for Commercialization · US

Inventors

Bradley Backes · San Francisco, US
Dustin J. Maly · Seattle, US
Scott A. Oakes · San Francisco, US
Feroz R. Papa · Oakland, US
Gayani Perera · Nugegoda, LK
Likun Wang · 安丰镇, CN

Key dates

Filing date	Mar 26, 2015
Grant date	Nov 20, 2018
Priority date	—
Expiry date	Mar 26, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Described herein, inter alia, are compositions and methods of using the same for modulating the activity of Ire1 using for example, substituted imidazopyrazine compounds.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.